Deprecated: Use of MediaWiki\Output\OutputPage::setIndexPolicy with index after noindex was deprecated in MediaWiki 1.43. [Called from MediaWiki\Output\OutputPage::setRobotPolicy in /home/forge/wikitrademarks.org/includes/Output/OutputPage.php at line 1008] in /home/forge/wikitrademarks.org/includes/debug/MWDebug.php on line 385
Category:Joseph M. Bosilevac of Clay Center NE (US) - WikiTrademarks Jump to content

Category:Joseph M. Bosilevac of Clay Center NE (US)

From WikiTrademarks
Revision as of 11:04, 31 March 2025 by Unknown user (talk) (Updating Category:Joseph_M._Bosilevac_of_Clay_Center_NE_(US))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Joseph M. Bosilevac of Clay Center NE (US)

Executive Summary

Joseph M. Bosilevac of Clay Center NE (US) is an inventor who has filed 1 patents. Their primary areas of innovation include involving nucleic acids (1 patents), MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay (1 patents), INDEXING SCHEME ASSOCIATED WITH SUBCLASSES (1 patents), and they have worked with companies such as The Florida State University Research Foundation, Inc. (1 patents). Their most frequent collaborators include (1 collaborations).

Patent Filing Activity

File:Joseph M. Bosilevac of Clay Center NE (US) Monthly Patent Applications.png

Technology Areas

File:Joseph M. Bosilevac of Clay Center NE (US) Top Technology Areas.png

List of Technology Areas

  • C12Q1/689 (involving nucleic acids): 1 patents
  • C12Q2600/16 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 1 patents
  • C12R2001/42 (INDEXING SCHEME ASSOCIATED WITH SUBCLASSES): 1 patents

Companies

File:Joseph M. Bosilevac of Clay Center NE (US) Top Companies.png

List of Companies

  • The Florida State University Research Foundation, Inc.: 1 patents

Collaborators

Subcategories

This category has the following 2 subcategories, out of 2 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.